Gankyrin is frequently overexpressed in breast cancer and is associated with ErbB2 expression (Q39218576)

10 September 2017

title

Gankyrin is frequently overexpressed in breast cancer and is associated with ErbB2 expression (English)

1 reference

10 September 2017

1 reference

Yeong Hwa Kim

1

1 reference

10 September 2017

Jang-Hee Kim

2

1 reference

10 September 2017

Yong Won Choi

3

1 reference

10 September 2017

Seo Kyung Lim

4

1 reference

10 September 2017

Hyunee Yim

5

1 reference

10 September 2017

Seok Yun Kang

6

1 reference

10 September 2017

Yong Sik Chung

7

1 reference

10 September 2017

Ga-Young Lee

8

1 reference

10 September 2017

Tae Jun Park

9

1 reference

10 September 2017

language of work or name

1 reference

28 December 2012

1 reference

Experimental and Molecular Pathology

10 September 2017

published in

1 reference

10 September 2017

volume

94

1 reference

10 September 2017

issue

2

1 reference

10 September 2017

page(s)

360-365

1 reference

The role of p53 in regulating genomic stability when DNA and RNA synthesis are inhibited

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.12.002

Strong correlation between results of fluorescent in situ hybridization and immunohistochemistry for the assessment of the ERBB2 (HER-2/neu) gene status in breast carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.12.002

Gankyrin is an ankyrin-repeat oncoprotein that interacts with CDK4 kinase and the S6 ATPase of the 26 S proteasome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.12.002

Prognostic factors of breast recurrence in the conservative management of early breast cancer: a 25-year follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.12.002

p28GANK overexpression accelerates hepatocellular carcinoma invasiveness and metastasis via phosphoinositol 3-kinase/AKT/hypoxia-inducible factor-1α pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.12.002

Controversies in pathology in early-stage breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.12.002

Reduced stability of retinoblastoma protein by gankyrin, an oncogenic ankyrin-repeat protein overexpressed in hepatomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.12.002

The oncoprotein gankyrin binds to MDM2/HDM2, enhancing ubiquitylation and degradation of p53

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.12.002

ERBB receptors and cancer: the complexity of targeted inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.12.002

Genomic Differences Between Pure Ductal Carcinoma In Situ of the Breast and that Associated with Invasive Disease: a Calibrated aCGH Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.12.002

ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.12.002

The crystal structure of gankyrin, an oncoprotein found in complexes with cyclin-dependent kinase 4, a 19 S proteasomal ATPase regulator, and the tumor suppressors Rb and p53

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.12.002

Novel insights into the INK4-CDK4/6-Rb pathway: counter action of gankyrin against INK4 proteins regulates the CDK4-mediated phosphorylation of Rb

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.12.002

HER2-positive status is an independent predictor for coexisting invasion of ductal carcinoma in situ of the breast presenting extensive DCIS component.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.12.002

X-ray structure of human gankyrin, the product of a gene linked to hepatocellular carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.12.002

Gankyrin promotes the proliferation of human pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.12.002

Gankyrin oncoprotein overexpression as a critical factor for tumor growth in human esophageal squamous cell carcinoma and its clinical significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.12.002

Sequential changes in hepatocarcinogenesis induced by diethylnitrosamine plus thioacetamide in Fischer 344 rats: induction of gankyrin expression in liver fibrosis, pRB degradation in cirrhosis, and methylation of p16(INK4A) exon 1 in hepatocellular

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.12.002

Retinoblastoma protein modulates gankyrin-MDM2 in regulation of p53 stability and chemosensitivity in cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.12.002

Prognostic factors for recurrence and cosmesis in 393 patients after radiation therapy for early mammary carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.12.002

Pathologic findings on re-excision of the primary site in breast cancer patients considered for treatment by primary radiation therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.12.002

Overexpression of a novel gene gankyrin correlates with the malignant phenotype of colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.12.002

Discovering a potent small molecule inhibitor for gankyrin using de novo drug design approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.12.002

Solution structure of the human oncogenic protein gankyrin containing seven ankyrin repeats and analysis of its structure--function relationship.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.12.002

10.1016/J.YEXMP.2012.12.002

7 January 2021

Identifiers

DOI

1 reference

release_nlqcg2up35gkzayqbsah6j3l4i

10 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nlqcg2up35gkzayqbsah6j3l4i

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference